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Abstract 
Although research suggests that hyperhomocysteinemia (Hhcy) influences the development of 
cardiovascular disease, the hypothesis that Hhcy specifically causes hypertension remains a 
relatively mysterious subject. Despite the suggestion that Hhcy is linked to hypertension, there 
currently are no guidelines on hypertension treatment related to serum homocysteine 
concentration.  
The following case discusses a 67-year-old Caucasian female with recently diagnosed 
hypertension. She presents to her primary care clinic for a three-week follow-up exam after 
beginning an antihypertensive regimen in accord with her diagnosis of essential hypertension. 
Her blood pressure remains uncontrolled, despite pharmacologic intervention.  
Hypertension is an illness seen commonly in primary care. Hypertension that is poorly controlled 
increases the risk of cardiovascular complications such as myocardial infarction, stroke, and 
heart failure; therefore, it is necessary to be knowledgeable about the causes and treatments of 
hypertension.  
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Background  
A 67-year-old Caucasian female presented to the clinic for a three-week follow-up after a 
recent diagnosis of essential hypertension, for which she was started on antihypertensive therapy. 
She reports a history of smoking, but has no additional past medical history. However, her family 
history is significant for coronary artery disease and diabetes. Despite pharmacologic 
antihypertensive therapy in conjunction with an active lifestyle, her blood pressure remains 
elevated.    
Hypertension has long been recognized as a modifiable risk factor for heart disease. The 
etiology of hypertension is not yet fully understood, but remains important as its prevalence 
continues to grow worldwide (Wang et al, 2014). For decades, there have been studies looking at 
the relationship between homocysteine levels and the risk of cardiovascular disease. More 
recently, elevated homocysteine, or hyperhomocysteinemia (Hhcy), has been viewed as a risk 
factor for elevated blood pressure in adults. It is necessary to consider the relationship between 
homocysteine and blood pressure as studies have proven that interventions (such as 
supplementation of folic acid) can reduce serum levels of homocysteine (Anderson, Ha Jee, 
Charleston, Narrett, & Appel, 2010). If, in fact, Hhcy can be linked to hypertension, it would be 
prudent for providers to know how to diagnose and treat this condition. 
Case Report 
History  
 A 67-year-old Caucasian female presents to the clinic for a follow-up exam after a recent 
diagnosis of essential hypertension. She was started on antihypertensive therapy three weeks ago, 
which consisted of Lisinopril 20 mg once daily. She has been monitoring her blood pressure 
daily, with an average systolic blood pressure reading in the 150’s.  
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 At this visit, she is feeling well except for a persistent dry cough, which has been present 
for the past three weeks. When asked about associated symptoms, she reports no fever, chills, 
wheezing, shortness of breath, or upper respiratory symptoms. She reports no increased anxiety 
or stress, and states “other than this cough, nothing has seemed out of the ordinary”. She does not 
mention that her cough is worse with exertion, nor does it interfere with daily activities. Other 
pertinent negatives include no chest pain, palpitations, dizziness, or syncope.  
Other than newly diagnosed hypertension, she denies comorbidities including 
dyslipidemia or diabetes. She gives a brief overview of her family history, which is concerning 
as both parents have undergone coronary artery bypass graft, indicating significant coronary 
artery disease. After mentioning this, she explains that at age 53 she had an episode of chest pain, 
which eventually led to an angiogram. Regarding the angiogram, she recalls “the cardiologist 
told me my arteries were clean at that time”. Her family history also includes a brother with 
diabetes.  
She is currently retired and lives an active lifestyle. She loves to swim, often 6 miles at a 
time, and participates in a water aerobics class at a nearby gym, three to four days per week. She 
has a 30 pack-year history of smoking, having quit more than 10 years ago. She does not 
consume alcohol and has never used any other form of drugs.  
 Her current medications include Lisinopril 20 mg once daily, in addition to a daily 
multivitamin. She uses no other over-the-counter or herbal medications, and denies any drug 
allergies.  
Physical Exam, Diagnosis, and Treatment Plan 
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The following vital signs are obtained at this visit: Blood pressure 160/98, heart rate 80, 
respiratory rate 20, and temperature 98.6 F. During her exam, she is pleasant and engaged in 
conversation, showing no signs of distress.  
The physical exam at this visit reveals clear conjunctiva without drainage, and pupils that 
are equal, round, and reactive to light and accommodation, bilaterally. Her funduscopic exam is 
unremarkable, bilaterally. No nasal mucosa inflammation or discharge is noted, which aids in 
ruling out an upper respiratory cause of her cough. Her oropharynx is pink, moist, and free of 
lesions or exudate. Her neck is supple, non-tender, and without masses. Her cardiovascular exam 
reveals a regular heart rate and rhythm, with no evidence of a murmur or adventitious heart 
sounds. Trace peripheral edema is noted to the lower extremities. Her breathing is regular and 
non-labored during the exam. Lung sounds are clear throughout all lung fields, with no wheezing 
or crackles noted. Her abdominal assessment is negative. She is alert and oriented to person, 
place, and time. Her skin is warm and dry to touch with no evidence of rash, bruising, or 
wounds.  
 No laboratory testing or diagnostics were obtained at this visit. Given the patient’s history 
and physical exam which indicate no signs of an infectious process, it is likely that her persistent 
dry cough is related to the ACE inhibitor started three weeks prior. After determining that her 
cough is likely an adverse effect of an ACE inhibitor, Lisinopril is discontinued. She is informed 
that her blood pressure should be less than 150/90, per JNC-8 guidelines on the treatment of 
hypertension. As such, she will need to start an antihypertensive from another drug class. In 
further reference to the JNC-8 guidelines on management of high blood pressure, 
Hydrochlorothiazide 25 mg once daily is prescribed (James et al., 2014). The patient is given 
information on this new prescription and questions are answered. She is encouraged to continue 
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water aerobics three to four days a week, and may monitor her blood pressure at home as 
desired. She is recommended to follow-up in four weeks for a recheck of her blood pressure, as 
well as lab work, due to the potential for Hydrochlorothiazide to alter electrolytes and renal 
function. Additionally, a fasting lipid panel will be ordered at her follow-up visit due to a 
significant family history of coronary artery disease, as well as a personal history of smoking. 
The patient is instructed to follow-up sooner than four weeks if her cough does not improve, or if 
she develops other concerning symptoms. She agrees with this treatment plan, and with follow-
up related to her diagnosis of hypertension.   
 As demonstrated in the previously discussed case report, treatment for hypertension is not 
always straightforward. Many factors play into the cause of hypertension, factors which may 
vary among individuals and alter treatment outcomes. It is important for providers to understand 
what factors influence hypertension, as having that understanding will allow for the most 
appropriate treatment to be given. In the past century, homocysteine was discovered to be a 
contributing factor in cardiovascular disease. In more recent years, research has also looked at 
how increased levels of homocysteine may directly affect blood pressure (Li et al., 2016).  
Literature Review  
Hyperhomocysteinemia has been investigated by researchers as a possible cause of 
hypertension in adults. To better understand how Hhcy may affect the cardiovascular system, it 
is essential to first understand what homocysteine is. Homocysteine is an amino acid which 
contains a sulphur compound formed via the biosynthesis of cysteine and methionine (also 
amino acids). It is largely formed via the replacement of a molecule from the amino acid 
methionine. Methionine is found to be plentiful in animal proteins (Ganguly & Alam, 2015). The 
most common causes of Hhcy are due to genetic or environmental reasons. For example, a 
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deficiency in vitamin B12 or folic acid can inhibit the ability of homocysteine to be broken 
down, rendering increased intracellular concentrations. The sulphur component found in 
homocysteine can cause oxidative damage, or the inhibition of antioxidant properties, within the 
tissues so the body cannot counteract the harmful effects of free radicals. Therefore, Hhcy can 
cause a hypercoagulable state and rapid proliferation (i.e. reproduction) of smooth muscle cells. 
Rapid proliferation of smooth muscle cells in the vessel endothelium may cause arterial stiffness 
and thus hypertension (Korzeniowska, Cieslewicz, Chmara, & Jablecka, 2015).   
Hyperhomocysteinemia is defined as a serum homocysteine level greater than 15 umol/L. 
Most healthy persons have a homocysteine level between 5.0 and 15.0 umol/L, depending on the 
method being used to interpret this value. A homocysteine level between 16 and 30 umol/L is 
defined as moderate, a level between 31 and 100 is reported as intermediate, and severe Hhcy is 
considered any value above 100 umol/L (Ganguly, 2015). As one source reports, the normal 
range for serum homocysteine concentration tends to increase with age. Consequently, this 
places adults at an increasing risk of Hhcy as they age (Korzeniowska et al., 2015). In caring for 
an aging adult population, the ability to determine the presence of Hhcy becomes important, as 
this may affect blood pressure.  
There are many reasons to consider the relationship between Hhcy and hypertension, 
with perhaps the most important reason being a reduction in the risk of cardiovascular morbidity 
and mortality (Lionakis, Mendrinos, Sanidas, Favatas, & Georgopoulou, 2012). Making the 
connection between Hhcy and blood pressure will aid in the development of hypertension 
treatment plans to reduce serum homocysteine levels.  
The review of literature surrounding this topic led to several types of studies that have 
been performed in multiple countries, with most studies being investigated in China. Although it 
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is not recent, the Framingham Heart Study, originally published in 2003, was the first study to 
look at whether increased serum homocysteine levels caused hypertension. The relevance of this 
source is proven through its frequent citation within more recent studies, and so, should be 
discussed within this case report. At the time that this prospective longitudinal study was 
completed, several cross-sectional studies had observed an increased risk of cardiovascular 
disease in the presence of Hhcy, but none had looked at whether it was the cause of high blood 
pressure (Sundstrom et al., 2003).  
The goal of the Framingham Heart study, was to investigate the progression of blood 
pressure in relation to serum homocysteine, over a four-year follow-up. Homocysteine levels 
were analyzed based on the following criteria: as sex-based quartiles; as Hhcy (which was 
considered > 14 umol/L); and as models with multiple variables known to influence blood 
pressure (i.e. diabetes mellitus, obesity, smoking, creatinine level, and blood pressure category). 
At the four-year follow-up exam, 360 of the 2,104 participants had developed hypertension. 
Rates were similar among genders, and those with homocysteine levels above 14 umol/L had a 
higher incidence of hypertension. However, in the models that had been adjusted for age and sex, 
and in the models with multiple variables, the correlation between homocysteine level and blood 
pressure elevation was not statistically significant. And so, the Framingham Heart Study 
concludes that Hhcy is likely a concomitant finding, rather than a causative factor in the 
development of hypertension (Sundstrom et al., 2003).  
Per Ganguly and Alam (2015) the role of homocysteine in the control of blood pressure 
deserves some attention, as blood pressure may facilitate the toxic effects of homocysteine on the 
cardiovascular system. Experimental and animal studies have shown a link between 
homocysteine and hypertension when an increase in blood pressure was seen after inducing 
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hyperhomocysteinemia. The resulting increase in blood pressure may be due to changes in 
vascular endothelial integrity. Cell culture studies performed in artificial environments have 
shown that with the administration of homocysteine, there was induction of oxidative stress to 
the vascular endothelium and decreased availability of nitric oxide. Without the vasodilatory 
effect of nitric oxide, the endothelium was less able to react to vasoconstriction, which increased 
blood pressure. This study also reports that impairments in vascular endothelium vasodilation 
have been noted in humans with acute or chronic Hhcy, suggesting that Hhcy does in fact 
contribute to hypertension (Ganguly & Alam, 2015).  
In further review of the literature, similar findings were discussed in the European 
Journal of Physiology, regarding the hypothesis of vascular endothelial injury due to oxidative 
stress. Peripheral circulation is, in part, controlled by both vasodilatory and vasoconstricting 
factors such as nitric oxide and oxidative stress, respectively. Hhcy influences peripheral blood 
flow primarily by impairing the actions of such vasodilators. A confounding effect is that Hhcy 
contributes to oxidative stress, which works against nitric oxide, so it is not able to generate its 
full potential of vasodilation. In one study, adults were given oral methionine which increased 
their homocysteine level and resulted in a reduction in flow-mediated vasodilation of the 
endothelium within the brachial artery. The reduction in dilation was significant, compared to 
adults with low levels of homocysteine. Thus, signifying that Hhcy is an independent risk factor 
for decreased function of arterial endothelium, and so a risk for hypertension. Two additional 
studies have found that oral methionine increases homocysteine levels, and impairs the action of 
endothelial dilatation in healthy adults. The findings of this study indicate that there is a positive 
correlation between Hhcy and alteration of vessel endothelium, which may cause arterial 
stiffness and hypertension (Toda & Okamura, 2016).  
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Korzeniowska et al. (2015) discuss, as many other studies have, the effects of endothelial 
dysfunction in the presence of elevated homocysteine levels. With that background, the authors 
of this study looked at the relation of homocysteine levels, to newly diagnosed essential 
hypertension in adults. Age and smoking were considered associated factors in this study. The 
patients who fell into the essential hypertension category per JNC VII criteria, had shown higher 
serum homocysteine (mean 15.23 umol/L) compared to the control group (mean 9.71 umol/L). 
Among participants, 28 percent had a homocysteine level of 15 umol/L or greater. Also, in those 
with hypertension who were smokers, homocysteine levels were higher than non-smokers. Age 
was the only factor shown to correlate with homocysteine level in healthy participants without 
hypertension (Korzeniowska et al., 2015). 
 A prospective Kailuan study, looked at homocysteine levels and the progression of blood 
pressure among a community cohort of 2427 men and women, over 2 years. Within the male 
cohort, the incidence of hypertension was most significant at a lower homocysteine level, and 
showed reduced progression of hypertension as homocysteine levels increased. Within the 
female cohort, there was not a significant correlation found between homocysteine level and 
blood pressure. This 2-year longitudinal study concluded that rather than Hhcy increasing the 
risk of hypertension, lower homocysteine levels might be a risk factor for the occurrence of high 
blood pressure (Wang et al., 2014). 
 In Northeast rural China, a large cross-sectional study looked at the independent 
association of Hhcy and hypertension among 7,130 people aged 35 years and older within the 
general population. Upon completion, a trend was seen between increased levels of 
homocysteine and the incidence of hypertension. After adjusting for patient variables such as 
age, body mass index, smoking, family history of hypertension, and comorbidities, the findings 
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of several logistic regression analyses demonstrated a significant association of Hhcy and high 
blood pressure among males, but this association was not seen in females. In addition, the 
prevalence of Hhcy was much higher in males than females, with a mean homocysteine level in 
men of 20.99 umol/L and 14.19 umol/L in women. Interestingly, the mean level of homocysteine 
in males within this study is significantly higher than the mean typically reported among studies 
completed in other countries, suggesting that future research should investigate environmental or 
cultural factors associated with homocysteine levels. The results of this study concluded that 
there was a positive correlation between Hhcy and the prevalence of hypertension in males, and 
that homocysteine levels tend to be higher in males than females (Li et al., 2016).  
 It has been noted within multiple studies, that folate intake may reduce blood pressure as 
it increases the activity of nitric oxide, which leads to vasodilation of vessels and reduced serum 
homocysteine levels (Anderson et al., 2010; Toda & Okamura, 2016; Van Dijk et al., 2015; Xun 
et al., 2012). One study looked at how the ingestion of folate affected the incidence of 
hypertension among young African American and Caucasian adults, over a 20-year follow-up. 
This follow-up study used data obtained from 6 follow-ups of the Coronary Artery Risk 
Development in Young Adults (CARDIA) study, which examined the progression of 
cardiovascular disease based on risk factors. While this study was directly focused on the link 
between hypertension and folate intake, it also assessed the relation between folate and 
homocysteine levels, looking for a potential mechanism as to why the former link exists. Of 
importance, were the examinations of how serum levels of folate related to homocysteine levels, 
how homocysteine concentration related to blood pressure, and the relation of serum 
homocysteine to newly diagnosed hypertension. The study found an inverse link between the 
level of folate in the blood and the level of homocysteine. Participants with higher levels of 
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folate had lower serum concentrations of homocysteine, and a lower incidence of hypertension. 
Furthermore, as homocysteine levels increased by 5 umol/L, systolic blood pressure increased by 
0.63 mmHg and diastolic blood pressure increased by 0.55 mmHg. Despite being unable to 
prove whether folate directly reduced serum homocysteine concentrations, the study did find that 
higher rates of hypertension were noted among those with higher concentrations of homocysteine 
(Xun et al., 2012).  
 Finally, although multiple studies make note of the hypothesis that Hhcy may contribute 
to hypertension, studies have failed to prove a strong predictable causation between Hhcy and 
hypertension. The literature available on this topic is insufficient, especially works within the 
past decade, indicating that further investigation is needed. It was found that Hhcy has been 
linked to an increased risk of atherosclerosis, heart failure, and stroke. The correlation between 
Hhcy and the previously mentioned cardiovascular diseases, provides plausible reason to 
continue researching the relationship between Hhcy and hypertension. 
Learning points 
• Hhcy has been proven in some instances to cause harm to vascular endothelial integrity 
via oxidative stress, owing to arterial stiffness which may contribute to hypertension.  
• The relationship between Hhcy and hypertension in adults are conflicting among studies, 
thus a definitive correlation cannot be made between the two.  
• There is a lack of high level evidence studies surrounding the topic of Hhcy and its effect 
on hypertension in adults.   
• It is suggested that future studies include monitoring of serum nitric oxide levels in 
participants, as this may give further insight to the relationship between Hhcy and 
hypertension.  
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